This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
CKD patients aged 18 to 90 years
You may not be if
no CKD patients, aged below 18 or above 90 years
Clareo Health | Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
